Unison Advisors LLC Buys 52 Shares of The Cigna Group (NYSE:CI)

Unison Advisors LLC boosted its position in shares of The Cigna Group (NYSE:CI) by 0.4% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,346 shares of the health services provider’s stock after purchasing an additional 52 shares during the period. Unison Advisors LLC’s holdings in The Cigna Group were worth $4,277,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Wedmont Private Capital lifted its position in shares of The Cigna Group by 2.5% in the third quarter. Wedmont Private Capital now owns 4,291 shares of the health services provider’s stock worth $1,460,000 after purchasing an additional 105 shares in the last quarter. CWM LLC increased its stake in The Cigna Group by 0.4% in the 3rd quarter. CWM LLC now owns 70,893 shares of the health services provider’s stock valued at $24,560,000 after buying an additional 298 shares during the last quarter. Future Financial Wealth Managment LLC bought a new stake in The Cigna Group during the 3rd quarter worth about $191,000. Strategic Wealth Partners Ltd. boosted its stake in shares of The Cigna Group by 3.3% during the 3rd quarter. Strategic Wealth Partners Ltd. now owns 1,398 shares of the health services provider’s stock worth $484,000 after buying an additional 45 shares during the last quarter. Finally, Brookstone Capital Management grew its holdings in shares of The Cigna Group by 3.1% in the 3rd quarter. Brookstone Capital Management now owns 1,338 shares of the health services provider’s stock valued at $464,000 after acquiring an additional 40 shares in the last quarter. 86.99% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on CI. JPMorgan Chase & Co. increased their price target on The Cigna Group from $435.00 to $438.00 and gave the company an “overweight” rating in a research report on Wednesday, August 21st. Piper Sandler assumed coverage on The Cigna Group in a report on Wednesday, June 26th. They issued an “overweight” rating and a $400.00 price objective for the company. Cantor Fitzgerald reissued an “overweight” rating and issued a $400.00 target price on shares of The Cigna Group in a research note on Tuesday, October 1st. Barclays upped their price target on shares of The Cigna Group from $393.00 to $405.00 and gave the stock an “overweight” rating in a research report on Friday, August 2nd. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $384.00 price objective on shares of The Cigna Group in a research report on Monday, September 9th. One equities research analyst has rated the stock with a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, The Cigna Group currently has an average rating of “Buy” and a consensus price target of $392.79.

The Cigna Group Stock Performance

Shares of NYSE:CI traded up $2.32 on Thursday, reaching $349.04. 117,800 shares of the company’s stock were exchanged, compared to its average volume of 1,480,248. The Cigna Group has a twelve month low of $253.95 and a twelve month high of $370.83. The company has a fifty day moving average of $348.19 and a 200-day moving average of $344.86. The company has a market capitalization of $99.15 billion, a price-to-earnings ratio of 28.46, a PEG ratio of 1.08 and a beta of 0.50. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.73.

The Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, August 1st. The health services provider reported $6.72 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.42 by $0.30. The business had revenue of $60.52 billion for the quarter, compared to the consensus estimate of $58.30 billion. The Cigna Group had a return on equity of 17.83% and a net margin of 1.70%. The firm’s quarterly revenue was up 24.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $6.13 earnings per share. On average, research analysts predict that The Cigna Group will post 28.48 EPS for the current fiscal year.

The Cigna Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 19th. Investors of record on Wednesday, September 4th were given a dividend of $1.40 per share. The ex-dividend date of this dividend was Wednesday, September 4th. This represents a $5.60 annualized dividend and a yield of 1.60%. The Cigna Group’s dividend payout ratio is 45.98%.

Insiders Place Their Bets

In related news, Director William J. Delaney III sold 2,691 shares of The Cigna Group stock in a transaction that occurred on Monday, August 19th. The shares were sold at an average price of $342.68, for a total value of $922,151.88. Following the transaction, the director now directly owns 17,539 shares of the company’s stock, valued at $6,010,264.52. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 0.60% of the company’s stock.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.